Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTSR1 | P30989 | 20/20 | 0.76 |
| ▸ | NTSR2 | O95665 | 18/20 | 0.76 |
| ▸ | SORT1 | Q99523 | 16/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1421598 | 0.96 | NTSR1 (0.72) | NTSR1NTSR2SORT1 | |
| SCHEMBL1421605 | 0.96 | NTSR1 (0.72) | NTSR1NTSR2SORT1 | |
| SCHEMBL1421525 | 0.96 | NTSR1 (0.72) | NTSR1NTSR2SORT1 | |
| SCHEMBL1421513 | 0.96 | NTSR1 (0.72) | NTSR1NTSR2SORT1 | |
| SCHEMBL1421888 | 0.95 | OPRD1 (0.69) | NTSR1NTSR2SORT1 | |
| SCHEMBL1421906 | 0.95 | OPRD1 (0.69) | NTSR1NTSR2SORT1 | |
| SCHEMBL1421938 | 0.95 | OPRD1 (0.69) | NTSR1NTSR2SORT1 | |
| SCHEMBL1421931 | 0.95 | OPRD1 (0.69) | NTSR1NTSR2SORT1 | |
| SCHEMBL30864885 | 0.95 | NTSR1 (0.78) | NTSR1NTSR2SORT1 | |
| SCHEMBL30775521 | 0.94 | NTSR1 (0.68) | NTSR1NTSR2SORT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12485191-B2 | Radiopharmaceuticals and methods of use thereof | BOARD OF REGENTS OF THE UNIVERISTY OF NEBRASKA (US) | 2025-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12485191-B2 | Radiopharmaceuticals and methods of use thereof | FOLH1, SSTR4, SLC18A2 | NTSR1 139/4885NTSR2 77/4885SORT1 1051/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.